Education and feedback for VHA pharmacists improved HF medication visits and prescribing, but personalized feedback did not ...

Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

The connection between brain, mental, and cardiovascular health needs considerable more attention, argues Maureen Hood, PhD, RN, Uniformed Services University.

A decision from the American Board of Medical Specialties will be made about a new cardiovascular board by this upcoming February.

Posters presented at the American Heart Association Scientific Sessions included results that show how persistent disparities ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Robert F. Kennedy Jr, a prominent antivaccine activist and former independent presidential candidate, has been nominated to ...

Male sex was also shown to be an independent risk factor for longer hospital stays and increased hospitalization costs at ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

The combination therapy of bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) was both tolerable and produced virologic ...

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...